Tags

Type your tag names separated by a space and hit enter

Rational Vaccine Design in the Time of COVID-19.
Cell Host Microbe. 2020 05 13; 27(5):695-698.CH

Abstract

As scientists consider SARS-CoV-2 vaccine design, we discuss problems that may be encountered and how to tackle them by what we term "rational vaccine design." We further discuss approaches to pan-coronavirus vaccines. We draw on experiences from recent research on several viruses including HIV and influenza, as well as coronaviruses.

Authors+Show Affiliations

The Scripps Research Institute, La Jolla, CA 92037, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA. Electronic address: burton@scripps.edu.Adimab, Lebanon, NH 03766, USA. Electronic address: laura.walker@adimab.com.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32407707

Citation

Burton, Dennis R., and Laura M. Walker. "Rational Vaccine Design in the Time of COVID-19." Cell Host & Microbe, vol. 27, no. 5, 2020, pp. 695-698.
Burton DR, Walker LM. Rational Vaccine Design in the Time of COVID-19. Cell Host Microbe. 2020;27(5):695-698.
Burton, D. R., & Walker, L. M. (2020). Rational Vaccine Design in the Time of COVID-19. Cell Host & Microbe, 27(5), 695-698. https://doi.org/10.1016/j.chom.2020.04.022
Burton DR, Walker LM. Rational Vaccine Design in the Time of COVID-19. Cell Host Microbe. 2020 05 13;27(5):695-698. PubMed PMID: 32407707.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Rational Vaccine Design in the Time of COVID-19. AU - Burton,Dennis R, AU - Walker,Laura M, PY - 2020/5/15/entrez PY - 2020/5/15/pubmed PY - 2020/5/19/medline SP - 695 EP - 698 JF - Cell host & microbe JO - Cell Host Microbe VL - 27 IS - 5 N2 - As scientists consider SARS-CoV-2 vaccine design, we discuss problems that may be encountered and how to tackle them by what we term "rational vaccine design." We further discuss approaches to pan-coronavirus vaccines. We draw on experiences from recent research on several viruses including HIV and influenza, as well as coronaviruses. SN - 1934-6069 UR - https://www.unboundmedicine.com/medline/citation/32407707/Rational_Vaccine_Design_in_the_Time_of_COVID_19_ DB - PRIME DP - Unbound Medicine ER -